Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VAPA antibody (C-Term)

This anti-VAPA antibody is a Rabbit Polyclonal antibody detecting VAPA in WB. Suitable for Human. This Primary Antibody has been cited in 5+ publications.
Catalog No. ABIN1881990

Quick Overview for VAPA antibody (C-Term) (ABIN1881990)

Target

See all VAPA Antibodies
VAPA (VAMP (Vesicle-Associated Membrane Protein)-Associated Protein A, 33kDa (VAPA))

Reactivity

  • 43
  • 30
  • 7
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 51
  • 11
Rabbit

Clonality

  • 52
  • 10
Polyclonal

Conjugate

  • 33
  • 6
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This VAPA antibody is un-conjugated

Application

  • 55
  • 18
  • 16
  • 13
  • 13
  • 7
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB)

Clone

RB40543
  • Binding Specificity

    • 15
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 182-210, C-Term

    Predicted Reactivity

    M, Rat

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This VAPA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 182-210 amino acids from the C-terminal region of human VAPA.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Furuita, Jee, Fukada, Mishima, Kojima: "Electrostatic interaction between oxysterol-binding protein and VAMP-associated protein A revealed by NMR and mutagenesis studies." in: The Journal of biological chemistry, Vol. 285, Issue 17, pp. 12961-70, (2010) (PubMed).

    Tuuf, Wistbacka, Mattjus: "The glycolipid transfer protein interacts with the vesicle-associated membrane protein-associated protein VAP-A." in: Biochemical and biophysical research communications, Vol. 388, Issue 2, pp. 395-9, (2009) (PubMed).

    Saita, Shirane, Natume, Iemura, Nakayama: "Promotion of neurite extension by protrudin requires its interaction with vesicle-associated membrane protein-associated protein." in: The Journal of biological chemistry, Vol. 284, Issue 20, pp. 13766-77, (2009) (PubMed).

    Prosser, Tran, Gougeon, Verly, Ngsee: "FFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation." in: Journal of cell science, Vol. 121, Issue Pt 18, pp. 3052-61, (2008) (PubMed).

    Lohoff, Weller, Bloch, Nall, Ferraro, Berrettini: "Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder." in: Journal of neural transmission (Vienna, Austria : 1996), Vol. 115, Issue 9, pp. 1339-45, (2008) (PubMed).

  • Target

    VAPA (VAMP (Vesicle-Associated Membrane Protein)-Associated Protein A, 33kDa (VAPA))

    Alternative Name

    VAPA

    Background

    The protein encoded by this gene is a type IV membrane protein. It is present in the plasma membrane and intracellular vesicles. It may also be associated with the cytoskeleton. This protein may function in vesicle trafficking, membrane fusion, protein complex assembly and cell motility. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified.

    Molecular Weight

    27893

    NCBI Accession

    NP_003565, NP_919415

    UniProt

    Q9P0L0
You are here:
Chat with us!